A citation-based method for searching scientific literature

Jennifer L Whitwell, Scott A Przybelski, Stephen D Weigand, David S Knopman, Bradley F Boeve, Ronald C Petersen, Clifford R Jack. Brain 2007
Times Cited: 405







List of co-cited articles
805 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
23


NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
21

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
20



An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.
Rahul S Desikan, Florent Ségonne, Bruce Fischl, Brian T Quinn, Bradford C Dickerson, Deborah Blacker, Randy L Buckner, Anders M Dale, R Paul Maguire, Bradley T Hyman,[...]. Neuroimage 2006
13


The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.
Clifford R Jack, Matt A Bernstein, Nick C Fox, Paul Thompson, Gene Alexander, Danielle Harvey, Bret Borowski, Paula J Britson, Jennifer L Whitwell, Chadwick Ward,[...]. J Magn Reson Imaging 2008
11

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.
Randall J Bateman, Chengjie Xiong, Tammie L S Benzinger, Anne M Fagan, Alison Goate, Nick C Fox, Daniel S Marcus, Nigel J Cairns, Xianyun Xie, Tyler M Blazey,[...]. N Engl J Med 2012
11

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.
Clifford R Jack, David S Knopman, William J Jagust, Ronald C Petersen, Michael W Weiner, Paul S Aisen, Leslie M Shaw, Prashanthi Vemuri, Heather J Wiste, Stephen D Weigand,[...]. Lancet Neurol 2013
11

Mild cognitive impairment: clinical characterization and outcome.
R C Petersen, G E Smith, S C Waring, R J Ivnik, E G Tangalos, E Kokmen. Arch Neurol 1999
11

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.
Bradford C Dickerson, Akram Bakkour, David H Salat, Eric Feczko, Jenni Pacheco, Douglas N Greve, Fran Grodstein, Christopher I Wright, Deborah Blacker, H Diana Rosas,[...]. Cereb Cortex 2009
655
11

Current concepts in mild cognitive impairment.
R C Petersen, R Doody, A Kurz, R C Mohs, J C Morris, P V Rabins, K Ritchie, M Rossor, L Thal, B Winblad. Arch Neurol 2001
10

FreeSurfer.
Bruce Fischl. Neuroimage 2012
9

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
Clifford R Jack, David S Knopman, William J Jagust, Leslie M Shaw, Paul S Aisen, Michael W Weiner, Ronald C Petersen, John Q Trojanowski. Lancet Neurol 2010
9

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Victor L Villemagne, Samantha Burnham, Pierrick Bourgeat, Belinda Brown, Kathryn A Ellis, Olivier Salvado, Cassandra Szoeke, S Lance Macaulay, Ralph Martins, Paul Maruff,[...]. Lancet Neurol 2013
9

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
9

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
D P Devanand, G Pradhaban, X Liu, A Khandji, S De Santi, S Segal, H Rusinek, G H Pelton, L S Honig, R Mayeux,[...]. Neurology 2007
483
9

Within-subject template estimation for unbiased longitudinal image analysis.
Martin Reuter, Nicholas J Schmansky, H Diana Rosas, Bruce Fischl. Neuroimage 2012
9


Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E Klunk, Henry Engler, Agneta Nordberg, Yanming Wang, Gunnar Blomqvist, Daniel P Holt, Mats Bergström, Irina Savitcheva, Guo-feng Huang, Sergio Estrada,[...]. Ann Neurol 2004
8

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.
Randy L Buckner, Abraham Z Snyder, Benjamin J Shannon, Gina LaRossa, Rimmon Sachs, Anthony F Fotenos, Yvette I Sheline, William E Klunk, Chester A Mathis, John C Morris,[...]. J Neurosci 2005
8

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.
Bruce Fischl, David H Salat, Evelina Busa, Marilyn Albert, Megan Dieterich, Christian Haselgrove, Andre van der Kouwe, Ron Killiany, David Kennedy, Shuna Klaveness,[...]. Neuron 2002
8

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.
Bruno Dubois, Howard H Feldman, Claudia Jacova, Steven T Dekosky, Pascale Barberger-Gateau, Jeffrey Cummings, André Delacourte, Douglas Galasko, Serge Gauthier, Gregory Jicha,[...]. Lancet Neurol 2007
7


Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.
G Chételat, B Landeau, F Eustache, F Mézenge, F Viader, V de la Sayette, B Desgranges, J-C Baron. Neuroimage 2005
391
7

Phases of A beta-deposition in the human brain and its relevance for the development of AD.
Dietmar R Thal, Udo Rüb, Mario Orantes, Heiko Braak. Neurology 2002
7

Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
Melissa E Murray, Neill R Graff-Radford, Owen A Ross, Ronald C Petersen, Ranjan Duara, Dennis W Dickson. Lancet Neurol 2011
530
7

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.
R C Petersen, P S Aisen, L A Beckett, M C Donohue, A C Gamst, D J Harvey, C R Jack, W J Jagust, L M Shaw, A W Toga,[...]. Neurology 2010
942
7

Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment.
Gaël Chételat, Béatrice Desgranges, Vincent De La Sayette, Fausto Viader, Francis Eustache, Jean-Claude Baron. Neuroreport 2002
277
7

Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.
Rachael I Scahill, Jonathan M Schott, John M Stevens, Martin N Rossor, Nick C Fox. Proc Natl Acad Sci U S A 2002
454
7

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Willemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, Betty M Tijms, Philip Scheltens, Frans R J Verhey, Pieter Jelle Visser, Pauline Aalten, Dag Aarsland, Daniel Alcolea,[...]. JAMA 2015
854
7

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
Ziad S Nasreddine, Natalie A Phillips, Valérie Bédirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L Cummings, Howard Chertkow. J Am Geriatr Soc 2005
7

MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study.
J L Whitwell, K A Josephs, M E Murray, K Kantarci, S A Przybelski, S D Weigand, P Vemuri, M L Senjem, J E Parisi, D S Knopman,[...]. Neurology 2008
245
7

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.
Tammie L S Benzinger, Tyler Blazey, Clifford R Jack, Robert A Koeppe, Yi Su, Chengjie Xiong, Marcus E Raichle, Abraham Z Snyder, Beau M Ances, Randall J Bateman,[...]. Proc Natl Acad Sci U S A 2013
236
6

Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition.
G Chételat, V L Villemagne, N Villain, G Jones, K A Ellis, D Ames, R N Martins, C L Masters, C C Rowe. Neurology 2012
129
6

Revising the definition of Alzheimer's disease: a new lexicon.
Bruno Dubois, Howard H Feldman, Claudia Jacova, Jeffrey L Cummings, Steven T Dekosky, Pascale Barberger-Gateau, André Delacourte, Giovanni Frisoni, Nick C Fox, Douglas Galasko,[...]. Lancet Neurol 2010
6

Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease.
G B Karas, P Scheltens, S A R B Rombouts, P J Visser, R A van Schijndel, N C Fox, F Barkhof. Neuroimage 2004
396
6

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
E H Corder, A M Saunders, W J Strittmatter, D E Schmechel, P C Gaskell, G W Small, A D Roses, J L Haines, M A Pericak-Vance. Science 1993
6

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
Rik Ossenkoppele, Daniel R Schonhaut, Michael Schöll, Samuel N Lockhart, Nagehan Ayakta, Suzanne L Baker, James P O'Neil, Mustafa Janabi, Andreas Lazaris, Averill Cantwell,[...]. Brain 2016
573
6

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
Brian A Gordon, Tyler M Blazey, Yi Su, Amrita Hari-Raj, Aylin Dincer, Shaney Flores, Jon Christensen, Eric McDade, Guoqiao Wang, Chengjie Xiong,[...]. Lancet Neurol 2018
227
6

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
Bruno Dubois, Howard H Feldman, Claudia Jacova, Harald Hampel, José Luis Molinuevo, Kaj Blennow, Steven T DeKosky, Serge Gauthier, Dennis Selkoe, Randall Bateman,[...]. Lancet Neurol 2014
6

What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus.
Anders M Fjell, Linda McEvoy, Dominic Holland, Anders M Dale, Kristine B Walhovd. Prog Neurobiol 2014
407
6

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.
Heiko Braak, Irina Alafuzoff, Thomas Arzberger, Hans Kretzschmar, Kelly Del Tredici. Acta Neuropathol 2006
6

MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease.
C R Jack, R C Petersen, P C O'Brien, E G Tangalos. Neurology 1992
659
6

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.
C R Jack, R C Petersen, Y C Xu, P C O'Brien, G E Smith, R J Ivnik, B F Boeve, S C Waring, E G Tangalos, E Kokmen. Neurology 1999
5

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.
Bradley T Hyman, Creighton H Phelps, Thomas G Beach, Eileen H Bigio, Nigel J Cairns, Maria C Carrillo, Dennis W Dickson, Charles Duyckaerts, Matthew P Frosch, Eliezer Masliah,[...]. Alzheimers Dement 2012
5


Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.
T Gómez-Isla, J L Price, D W McKeel, J C Morris, J H Growdon, B T Hyman. J Neurosci 1996
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.